Die Suchmaschine für Unternehmensdaten in Europa
EU-Förderung (4.013.445 €): Schnelle Biomechanik-Simulation für personalisiertes klinisches Design Hor 28.08.2017 EU-Rahmenprogramm für Forschung und Innovation "Horizont"
Auf einen Blick
Text
Schnelle Biomechanik-Simulation für personalisiertes klinisches Design
Clinical experts make design decisions on treatments, interventions, or on devices. ICT empowers them with patient-specific simulation models that enable better-informed design decisions. But patient-specific computational medicine is currently cumbersome, slow, and unintuitive; it relies on complex processing by technical experts, and it is hence far from reaching its full potential on clinical design, and scarcely used. RAINBOW envisions next-generation biomechanics simulation and optimization tools for personalized clinical design that are rapidly setup for a particular patient, have a fast learning curve, are easy-to-use by clinical experts, and do not require intervention by a technical team. Research objectives entail automated processing of patient data; automated setup of representations and parameters, capability to manage variance across patients; robust and accurate simulation as a latent part of design tools; and fast optimization methods that allow intuitive exploration of the design space. Novel computational methods will be created to reach the objective of rapid biomechanics simulation. RAINBOW will apply research solutions for diagnosis, prognosis, monitoring, surgical training, planning, guidance, design of prosthetics, implants, and medical devices, and will address health conditions such as osteoarthritis, scoliosis, hearing impairment, cardiovascular diseases, obesity etc. RAINBOW has 5 excellent academic participants: UCPH (medical imagine, machine learning), URJC (data-driven modeling), UL (computational mechanics), CARDIFF (model reduction), AAU and one hospital HH (bone modeling) and 8 industries 3Shape (prosthesis), Kitware (imaging), Insimo (surgical simulation), GMV (eHealth), Simpleware (CAD/CAE), inuTech (numerics), Anatascope (Patient specific modeling) and Next-Limit (CFD). This combined expertise will ensure diverse impact and training of highly qualified individuals.
Geförderte Unternehmen:
| Firmenname | Förderungssumme |
| Anatoscope | ? |
| 3Shape AS | 290.082 € |
| 3Shape Trios AS | 0,00 € |
| Aalborg Universitet | 290.082 € |
| Cardiff University | 273.288 € |
| GMV Soluciones Globales Internet SA | 247.873 € |
| Kobenhavns Universitet | 789.667 € |
| Region Hovedstaden | 80.578 € |
| Synopsys (Northern Europe) Ltd. | 546.576 € |
| Universidad Rey Juan Carlos | 743.619 € |
| Universite Du Luxembourg | 751.680 € |
Quelle: https://cordis.europa.eu/project/id/764644
Diese Bekanntmachung wurde von Englisch nach Deutsch übersetzt. Die Bekanntmachung bezieht sich auf einen vergangenen Zeitpunkt, und spiegelt nicht notwendigerweise den heutigen Stand wider. Der letzte verfügbare Stand wird auf folgender Seite wiedergegeben: Anatoscope SAS, Meylan, Frankreich.
